Daniel Hume serves as Executive at TG THERAPEUTICS, INC., where they oversee executive responsibilities. Since joining the company, Daniel Hume has executed 18 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 19, 2024 involved receiving (via award) 22,250 shares valued at $0.
Daniel Hume currently holds 240,489 shares of TG THERAPEUTICS, INC. (TGTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel Hume has been a net neutral trader of TGTX stock. They have purchased $0 and sold $0 worth of shares.
Daniel Hume's most recent insider trade was on Jun 19, 2024, when they sold 22,250 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 20, 2022 | TGTX | $0 | Award | 43,732 | $N/A | Discretionary |
| Jun 18, 2021 | TGTX | $0 | Award | 20,000 | $N/A | Discretionary |
| Feb 25, 2021 | NHLD | $202.0K | Tender | 62,151 | $3.25 | Discretionary |
| Jun 22, 2020 | TGTX | $0 | Award | 15,000 | $N/A | Discretionary |
| Jun 10, 2020 | STML | $0 | Tender | 35,468 | $N/A | Discretionary |
| Feb 13, 2020 | NHLD | $0 | Option Exercise | 5,160 | $N/A | Discretionary |
| Feb 12, 2020 | NHLD | $0 | Option Exercise | 3,496 | $N/A | Discretionary |
| Feb 12, 2020 | NHLD | $0 | Option Exercise | 25,000 | $N/A | Discretionary |
| Sep 17, 2019 | TGTX | $0 | Award | 27,048 | $N/A | Discretionary |
| Jun 25, 2019 | STML | $0 | Award | 15,000 | $N/A | Discretionary |
| Feb 12, 2019 | NHLD | $0 | Option Exercise | 25,000 | $N/A | Discretionary |
| Feb 12, 2019 | NHLD | $0 | Option Exercise | 3,495 | $N/A | Discretionary |
| Jun 26, 2018 | TGTX | $0 | Award | 15,000 | $N/A | Discretionary |
| Jun 21, 2018 | STML | $0 | Award | 20,468 | $N/A | Discretionary |
| Jun 16, 2017 | TGTX | $0 | Award | 15,000 | $N/A | Discretionary |
| Jul 6, 2016 | TGTX | $0 | Award | 12,459 | $N/A | Discretionary |